Researchers Develop New Tools to Detect Parkinson’s Disease Earlier
Scientists are testing devices that analyze handwriting, tremors, and bodily fluids to identify Parkinson’s disease before symptoms become obvious. The approaches aim to address the shortage of specialists and support earlier intervention.
Science NewsNeurologist David Standaert at the University of Alabama at Birmingham says he can often identify Parkinson’s disease within minutes by observing tremors, reduced arm swing, softer voice, and limited facial expression. Standaert states that more than 1 million people in the United States have the disease and that fewer than 1,000 movement disorder specialists are available to diagnose them.
He notes that the number of cases is rising as the population ages.
Standaert explains that Parkinson’s varies widely between patients, with differences in symptom onset, severity, and progression rate. He says no two patients present identically. Diagnosis currently relies on movement-related symptoms and, in uncertain cases, a DaTscan imaging test that costs about $3,000 and takes several hours.
Chen at the University of California, Los Angeles, has developed a soft ball that measures hand tremors through magnetoelastic signals when squeezed. Chen’s team reported in February that the device detects pressures below one kilopascal. Chen has also created a pen that records tremors during writing and an intelligent keyboard that tracks typing pressure patterns.
He says daily use of the keyboard could flag changes that indicate early disease. Stanford movement disorder specialist Kathleen Poston says dozens of drugs targeting the underlying causes of Parkinson’s are now in clinical trials. She states that these treatments differ from current symptom-management options.
Key Facts
Story Timeline
2 events- February
Jun Chen’s team reported a soft ball device that detects hand tremors below one kilopascal.
1 sourceScience News - Recent years
Dozens of drugs targeting root causes of Parkinson’s entered clinical trials.
1 sourceScience News
Potential Impact
- 01
Earlier detection could allow patients to enter clinical trials for disease-modifying drugs.
- 02
New devices may reduce reliance on specialist evaluations for initial screening.
Transparency Panel
Related Stories
NprWHO Director Visits Congo as Ebola Outbreak Spreads
The head of the World Health Organization arrived in Kinshasa to support efforts against a rare Ebola strain. Health workers face equipment shortages, community distrust, and armed conflict in affected provinces.
medpagetoday.comFDA Panel Recommends XFG Variant for Fall Covid Shots
Replimune will submit an application to the FDA for the third time. Pfizer and Innovent Biologics reached a collaboration agreement valued at up to $10.5 billion.
Benzinga Publishes Article on Biotech Stocks During Pandemic Recovery
Benzinga published an article titled 'Best Biotech Stocks Right Now' that addresses the sector's position during global recovery from the pandemic. The piece notes government institutions and professional traders are focusing on biotech companies for vaccine and booster developme…